Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Melanoma and skin cancer Clinical Trials

Protocol Number Title
2010IS024
Phase IV Randomized Study of Two Dose Levels of Targretin(R) Capsules in Patients with Refractory Cutaneous T-cell Lymphoma
2011IS132
A multi-center, double-blind, placebo controlled, adaptive, Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post Resection Melanoma Patients with a High Risk of Recurrence (MAVIS)
2012CG003
CITN11-02: A phase 1 study of recombinant human IL15 (rhIL15) in adults with advanced solid tumors
2014CG076
CITN-06:A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803, a Novel Recombinant IL-15 Complex in Patients with Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
2015CG012
COG ADVL1412 - A Phase 1/2 Study of Nivolumab (IND# 124729) in Children, Adolescents, and Young Adults with Recurrent or Refractory Solid Tumors as a Single Agent and in Combination with Ipilimumab Additional Title: ADVL1412-Bristol-Myers Squibb Company

5 trials displayed

  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on